Phase II multicenter study of iodine-131 anti-B1 antibody consolidation for patients with diffuse large B-cell non-Hodgkin's lymphoma following first-line CHOP

Trial Profile

Phase II multicenter study of iodine-131 anti-B1 antibody consolidation for patients with diffuse large B-cell non-Hodgkin's lymphoma following first-line CHOP

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2013

At a glance

  • Drugs Iodine-131 tositumomab (Primary)
  • Indications Diffuse large B cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Jun 2013 The recruitment status is unknown, not recently verified, according to ClinicalTrials.gov.
    • 25 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top